Ranbaxy gets tentative FDA nod to make, market hypertension treatment drug |
|
|
|
Published
:
Wed, 20 Jun 2007 14:33
|
MUMBAI (Thomson Financial) - India's Ranbaxy Laboratories Ltd said it received tentative approval from the US Food and Drug Administration to manufacture and market amlodipine besylate tablets of 2.5 mg, 5 mg and 10 mg strengths.Amlodipine besylate tablets treat hypertension, which can be used either alone or in combination with other anti-hypertensive agents. They are marketed in the US by Pfizer as Norvasc.Total annual market sales for amlodipine besylate tablets were 2.79 bln usd, as per data from IMS in March, Ranbaxy said in a release to the Bombay Stock Exchange.ami.shah@thomson.comami/ssa/rfwCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
Print this Story
Ranbaxy gets tentative OK for Allegra 